CUV 0.71% $14.09 clinuvel pharmaceuticals limited

He doesn't control the share price? Sure they could have...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,343 Posts.
    lightbulb Created with Sketch. 4384
    He doesn't control the share price? Sure they could have engaged better with shareholders, but I actually think he has performed incredibly well, surely people here also have experience of companies that do nothing but bleed shareholders for cash? Under Wolgen's leadership this company was brought from literally nothing to a market leader in melanocortins with a monopoly position, delivering strong and growing sales and cash flows. Sure the past few years haven't been that great (share price wise only, fundamentally it has been great), but he's been here a lot longer than 5 years and the share price has done very well over a longer time frame. I did expect this news but I'm very glad we got it, as I do indeed believe that he is best suited to make this a household name by 2026. I do firmly believe that so long as they continue to deliver on the fundamentals, the share price will eventually take care of itself.
    Last edited by TheAnalyst007: 28/06/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.